- Cocoon Bioscience has closed a €15 million ($15.9 million) round to grow its high-value proteins business, which includes developing recombinant proteins for cultivated meat growth media.
- The company will use the new funds to scale its business and build out its forthcoming production facilities in Spain.
- Columbus Venture Partners and Cleon Capital led the round with participation from Viscofan, North South Ventures and others.
** Click here to read the full-text **